<DOC>
	<DOCNO>NCT01051037</DOCNO>
	<brief_summary>The purpose study demonstrate combine stereotactic body radiotherapy radiofrequency ablation safe patient lung tumor near central airway .</brief_summary>
	<brief_title>Stereotactic Body Radiotherapy Radiofrequency Ablation Lung Tumors Near Central Airways</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<criteria>Histologically confirm primary lung cancer , lung metastasis another primary , recurrent tumor set prior RFA cryotherapy Tumors &lt; 2 cm trachea zone proximal bronchial tree ( central tumor ) Each tumor &lt; 5 cm size prior treatment Medically inoperable patient determine multidisciplinary thoracic tumor board , medically operable patient refuse surgery Criterion medical inoperability include : Overall clinical assessment UCLA thoracic tumor board Reduced Pulmonary Function ( FEV1 , DLCO , etc ) base one major two minor criterion describe : Modified ACOSOG Criteria medical inoperability : Major Criteria : FEV1 % &lt; 50 % &lt; 1L DLCO &lt; 50 % Minor Criteria : Age &gt; 75 , FEV1 5160 % predict , FEV1 11.2L , DLCO 51 % 60 % predict , pulmonary hypertension , poor leave ventricular function ( EF &lt; 40 % less ) , rest exercise arterial pO2 &lt; 55 mmHg , pCO2 &gt; 45 mmHg Age &gt; 18 year old KPS &gt; 70 If woman childbearing potential , negative urine serum pregnancy test must document . Ability understand willingness sign write informed consent Prior thoracic radiation near target interest More 2 central tumor target per patient Active infection require systemic antibiotic</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>lung tumor</keyword>
	<keyword>central airway</keyword>
</DOC>